Alice Li Yang, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yang’s office at (800) 597-2234 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A87725 · Current
Licensed to practise in California · since 2004 · expires 2027-11-30 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$74,943
Medicare paid this office $74,943 for 364 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Biopsy of large bowel using a flexible endoscope | 141 | $20,942 | $149 |
| Short return visit (20+ min) | 140 | $15,277 | $78 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $8,872 | $240 |
| Return visit (30+ min) | 70 | $7,206 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $5,892 | $89 |
See all 9 services
| Biopsy of large bowel using a flexible endoscope | 141 | $20,942 | $149 |
| Short return visit (20+ min) | 140 | $15,277 | $78 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 37 | $8,872 | $240 |
| Return visit (30+ min) | 70 | $7,206 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $5,892 | $89 |
| New patient visit (45+ min) | 26 | $3,910 | $150 |
| New patient visit (30+ min) | 28 | $2,858 | $102 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,268 | $206 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,287 | $117 |
Procedures Medicare counted
| Colonoscopy | 62 | More than 68% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 94 | More than 75% of doctors who do this |
Who their Medicare patients are
364 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 10% · Women 74% · Also on Medicaid 9% · Health risk score 1.03. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 70% · Coronary heart disease 23% · Diabetes 22% · Chronic kidney disease 19% · Cancer 16% · Depression 16% · Atrial fibrillation 15% · Heart failure 9% · COPD 8% · Stroke 7% · Dementia 6%.
The office billed $662,413, Medicare allowed $96,170 and paid $74,943; for 647 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 364 | 647 | 75 | 1.03 | $662,413 | $74,943 |
| 2023 | 327 | 588 | 75 | 0.92 | $583,270 | $71,474 |
| 2022 | 321 | 650 | 75 | 1.04 | $602,478 | $74,767 |
| 2021 | 317 | 701 | 75 | 1.12 | $594,244 | $81,549 |
| 2020 | 297 | 589 | 75 | 1.17 | $442,601 | $59,311 |
| 2019 | 319 | 730 | 74 | 0.98 | $591,460 | $74,200 |
| 2018 | 182 | 389 | 72 | 0.94 | $294,649 | $37,068 |
| 2017 | 213 | 545 | 73 | 1.06 | $404,778 | $54,838 |
| 2016 | 155 | 290 | 73 | 1.20 | $205,825 | $37,219 |
| 2015 | 149 | 302 | 72 | 1.38 | $224,407 | $42,277 |
| 2014 | 136 | 268 | 72 | 1.34 | $183,128 | $32,883 |
| 2013 | 212 | 469 | 74 | 1.77 | $120,541 | $38,957 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 54 | $13,249 | $245 |
| Biopsy of large bowel using a flexible endoscope | 104 | $13,222 | $127 |
| Short return visit (20+ min) | 110 | $11,964 | $76 |
| Return visit (30+ min) | 56 | $6,862 | $118 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $5,717 | $97 |
| New patient visit (45+ min) | 34 | $4,993 | $147 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,375 | $211 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,533 | $211 |
| New patient visit (30+ min) | 26 | $2,514 | $97 |
2022: 10 services
| Biopsy of large bowel using a flexible endoscope | 115 | $13,959 | $121 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 53 | $12,446 | $235 |
| Short return visit (20+ min) | 121 | $11,859 | $73 |
| Return visit (30+ min) | 75 | $9,218 | $115 |
| New patient visit (45+ min) | 45 | $6,804 | $151 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 69 | $6,602 | $94 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,184 | $212 |
| New patient visit (30+ min) | 18 | $1,569 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,415 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,114 | $66 |
2021: 9 services
| Biopsy of large bowel using a flexible endoscope | 107 | $13,861 | $130 |
| Short return visit (20+ min) | 112 | $13,568 | $82 |
| Return visit (30+ min) | 97 | $12,103 | $111 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 43 | $10,214 | $238 |
| New patient visit (45+ min) | 53 | $7,313 | $138 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 77 | $7,229 | $90 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,139 | $209 |
| New patient visit (30+ min) | 21 | $1,874 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,358 | $65 |
2020: 12 services
| Biopsy of large bowel using a flexible endoscope | 68 | $9,540 | $140 |
| Short return visit (20+ min) | 101 | $8,281 | $63 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 26 | $6,276 | $241 |
| New patient visit (30+ min) | 50 | $4,922 | $98 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 52 | $4,806 | $92 |
| New patient visit (45+ min) | 34 | $4,622 | $136 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,566 | $210 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,723 | $94 |
| Return visit (30+ min) | 24 | $2,462 | $98 |
| Short return visit | 32 | $1,364 | $43 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,362 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,214 | $58 |
2019: 11 services
| New patient visit (45+ min) | 102 | $14,211 | $139 |
| Biopsy of large bowel using a flexible endoscope | 93 | $13,540 | $143 |
| Short return visit (20+ min) | 115 | $11,486 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 76 | $8,312 | $103 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 36 | $8,116 | $225 |
| Return visit (30+ min) | 54 | $5,406 | $97 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $3,019 | $216 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,374 | $216 |
| New patient visit (30+ min) | 18 | $1,559 | $87 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 74 | $388 | $5 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 12 | $104 | $9 |
2018: 7 services
| Short return visit (20+ min) | 84 | $8,095 | $63 |
| New patient visit (45+ min) | 59 | $7,951 | $135 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $4,912 | $234 |
| Biopsy of large bowel using a flexible endoscope | 36 | $4,108 | $114 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,504 | $100 |
| Return visit (30+ min) | 12 | $1,046 | $87 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 44 | $204 | $5 |
2017: 11 services
| New patient visit (45+ min) | 99 | $12,879 | $130 |
| Return visit (30+ min) | 81 | $10,245 | $88 |
| Short return visit (20+ min) | 48 | $3,668 | $68 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 35 | $3,480 | $99 |
| Biopsy of large bowel using a flexible endoscope | 22 | $3,312 | $151 |
| Biopsy of large bowel using a flexible endoscope | 22 | $2,823 | $128 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $2,574 | $234 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,810 | $95 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 36 | $168 | $5 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 22 | $165 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 11 | $127 | $12 |
2016: 5 services
| New patient visit (45+ min) | 64 | $9,131 | $143 |
| Return visit (30+ min) | 59 | $7,727 | $91 |
| New patient visit (60+ min) | 23 | $4,077 | $177 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $3,353 | $124 |
| Biopsy of large bowel using a flexible endoscope | 20 | $2,886 | $144 |
2015: 8 services
| New patient visit (45+ min) | 54 | $8,269 | $153 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 19 | $5,728 | $286 |
| Return visit (30+ min) | 41 | $5,518 | $104 |
| Biopsy of large bowel using a flexible endoscope | 33 | $5,474 | $161 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,989 | $190 |
| New patient visit (30+ min) | 36 | $3,710 | $103 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $3,132 | $112 |
| Short return visit (20+ min) | 18 | $1,085 | $57 |
2014: 8 services
| Biopsy of large bowel using a flexible endoscope | 30 | $5,568 | $186 |
| Short return visit (20+ min) | 42 | $4,059 | $61 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,739 | $187 |
| Return visit (30+ min) | 28 | $2,702 | $97 |
| New patient visit (30+ min) | 28 | $2,477 | $88 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,342 | $106 |
| New patient visit (45+ min) | 16 | $2,298 | $144 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,461 | $122 |
2013: 10 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 70 | $6,449 | $34 |
| Short return visit (20+ min) | 65 | $5,550 | $65 |
| New patient visit (45+ min) | 31 | $4,535 | $146 |
| Biopsy of large bowel using a flexible endoscope | 13 | $2,629 | $202 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,261 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $2,214 | $130 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,296 | $118 |
| New patient visit (30+ min) | 13 | $1,291 | $99 |
| Return visit (30+ min) | 11 | $1,097 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $627 | $57 |
Drugs they prescribed that Part D paid
$114,687
Pharmacies billed $114,687 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 709) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
613 generic and 96 brand-name prescriptions · $114,687 in drug cost · 19 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 25 | $15,198 | $608 |
| Dexlansoprazole Dr | 13 | $4,849 | $373 |
| Sod Sulf-Potass Sulf-Mag Sulf | 53 | $3,696 | $70 |
| Peg 3350-Electrolyte | 98 | $1,766 | $18 |
| Pantoprazole | 95 | $1,483 | $16 |
See all 11 drugs
| Linzess | 25 | $15,198 | $608 |
| Dexlansoprazole Dr | 13 | $4,849 | $373 |
| Sod Sulf-Potass Sulf-Mag Sulf | 53 | $3,696 | $70 |
| Peg 3350-Electrolyte | 98 | $1,766 | $18 |
| Pantoprazole | 95 | $1,483 | $16 |
| Famotidine | 158 | $1,151 | $7 |
| Cholestyramine | 21 | $1,151 | $55 |
| Omeprazole | 88 | $864 | $10 |
| Dicyclomine | 26 | $598 | $23 |
| Esomeprazole Magnesium | 16 | $446 | $28 |
| Lactulose | 13 | $225 | $17 |
Year by year
| 2024 | 709 | 272 | 0% (0) | 14% | $114,687 |
| 2023 | 671 | 242 | 0% (0) | None | $120,238 |
| 2022 | 570 | 224 | 0% (0) | 31% | $99,551 |
| 2021 | 527 | 216 | None | None | $107,119 |
| 2020 | 442 | 162 | 0% (0) | 30% | $73,641 |
| 2019 | 382 | 181 | 0% (0) | 41% | $89,480 |
| 2018 | 378 | 175 | 0% (0) | 43% | $71,197 |
| 2017 | 443 | 204 | 0% (0) | 40% | $69,183 |
| 2016 | 520 | 192 | 0% (0) | 37% | $91,376 |
| 2015 | 671 | 247 | None | None | $330,156 |
| 2014 | 591 | 260 | None | 45% | $74,310 |
| 2013 | 669 | 229 | None | 50% | $110,601 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Linzess | 42 | $26,568 | $633 |
| Zenpep | 11 | $12,750 | $1,159 |
| Dexlansoprazole Dr | 15 | $7,297 | $486 |
| Sod Sulf-Potass Sulf-Mag Sulf | 33 | $2,535 | $77 |
| Peg 3350-Electrolyte | 89 | $1,937 | $22 |
| Pantoprazole | 76 | $1,904 | $25 |
| Famotidine | 133 | $1,672 | $13 |
| Cholestyramine | 19 | $1,410 | $74 |
| Suprep | 12 | $1,364 | $114 |
| Omeprazole | 82 | $913 | $11 |
| Lactulose | 14 | $552 | $39 |
| Esomeprazole Magnesium | 12 | $434 | $36 |
| Dicyclomine | 15 | $272 | $18 |
2022: 11 drugs
| Linzess | 49 | $30,100 | $614 |
| Zenpep | 11 | $12,034 | $1,094 |
| Dexilant | 17 | $10,750 | $632 |
| Suprep | 49 | $5,629 | $115 |
| Cholestyramine | 25 | $2,384 | $95 |
| Pantoprazole | 95 | $1,605 | $17 |
| Famotidine | 75 | $1,214 | $16 |
| Peg 3350-Electrolyte | 60 | $1,162 | $19 |
| Omeprazole | 65 | $905 | $14 |
| Dicyclomine | 13 | $773 | $59 |
| Gavilyte-C | 16 | $242 | $15 |
2021: 10 drugs
| Linzess | 34 | $18,594 | $547 |
| Zenpep | 13 | $14,040 | $1,080 |
| Dexilant | 28 | $13,247 | $473 |
| Suprep | 48 | $5,324 | $111 |
| Pantoprazole | 80 | $1,702 | $21 |
| Famotidine | 47 | $1,296 | $28 |
| Omeprazole | 78 | $1,133 | $15 |
| Dicyclomine | 29 | $746 | $26 |
| Peg 3350-Electrolyte | 39 | $630 | $16 |
| Gavilyte-C | 17 | $228 | $13 |
2020: 11 drugs
| Dexilant | 41 | $18,107 | $442 |
| Viberzi | 11 | $14,871 | $1,352 |
| Budesonide Ec | 11 | $3,499 | $318 |
| Suprep | 26 | $2,716 | $104 |
| Cholestyramine | 11 | $1,952 | $177 |
| Pantoprazole | 61 | $1,227 | $20 |
| Omeprazole | 93 | $1,118 | $12 |
| Famotidine | 27 | $849 | $31 |
| Dicyclomine | 29 | $822 | $28 |
| Peg 3350-Electrolyte | 35 | $497 | $14 |
| Gavilyte-N | 29 | $373 | $13 |
2019: 10 drugs
| Dexilant | 28 | $11,066 | $395 |
| Suprep | 70 | $7,043 | $101 |
| Cholestyramine | 15 | $2,541 | $169 |
| Budesonide Ec | 15 | $2,409 | $161 |
| Omeprazole | 41 | $740 | $18 |
| Peg 3350-Electrolyte | 35 | $663 | $19 |
| Pantoprazole | 41 | $658 | $16 |
| Dicyclomine | 11 | $378 | $34 |
| Gavilyte-N | 21 | $335 | $16 |
| Ranitidine | 18 | $209 | $12 |
2018: 8 drugs
| Suprep | 97 | $8,851 | $91 |
| Budesonide Ec | 12 | $6,891 | $574 |
| Dexilant | 15 | $6,335 | $422 |
| Mesalamine | 11 | $5,577 | $507 |
| Omeprazole | 62 | $795 | $13 |
| Pantoprazole | 42 | $535 | $13 |
| Ranitidine | 29 | $299 | $10 |
| Peg 3350-Electrolyte | 13 | $219 | $17 |
2017: 6 drugs
| Suprep | 119 | $10,441 | $88 |
| Omeprazole | 90 | $1,016 | $11 |
| Ranitidine | 39 | $642 | $16 |
| Pantoprazole | 47 | $522 | $11 |
| Peg 3350-Electrolyte | 14 | $219 | $16 |
| Famotidine | 11 | $101 | $9 |
2016: 13 drugs
| Dexilant | 36 | $8,469 | $235 |
| Suprep | 39 | $3,240 | $83 |
| Budesonide Ec | 16 | $2,914 | $182 |
| Esomeprazole Magnesium | 14 | $2,473 | $177 |
| Pantoprazole | 94 | $1,101 | $12 |
| Omeprazole | 71 | $954 | $13 |
| Peg 3350-Electrolyte | 39 | $657 | $17 |
| Lansoprazole | 13 | $485 | $37 |
| Dicyclomine | 22 | $258 | $12 |
| Gavilyte-N | 11 | $224 | $20 |
| Propranolol | 13 | $223 | $17 |
| Ranitidine | 23 | $215 | $9 |
| Gabapentin | 17 | $204 | $12 |
2015: 15 drugs
| Dexilant | 53 | $11,675 | $220 |
| Linzess | 22 | $6,362 | $289 |
| Nexium | 11 | $5,190 | $472 |
| Budesonide Ec | 15 | $4,452 | $297 |
| Suprep | 30 | $2,448 | $82 |
| Peg 3350-Electrolyte | 70 | $1,207 | $17 |
| Pantoprazole | 103 | $1,126 | $11 |
| Gavilyte-N | 50 | $975 | $19 |
| Omeprazole | 75 | $971 | $13 |
| Lansoprazole | 18 | $728 | $40 |
| Propranolol | 28 | $453 | $16 |
| Sulfasalazine | 13 | $317 | $24 |
| Dicyclomine | 25 | $195 | $8 |
| Gabapentin | 19 | $166 | $9 |
| Ranitidine | 12 | $74 | $6 |
2014: 13 drugs
| Dexilant | 66 | $12,961 | $196 |
| Amitiza | 17 | $5,040 | $296 |
| Linzess | 11 | $2,800 | $255 |
| Peg-3350 | 84 | $1,391 | $17 |
| Suprep | 16 | $1,245 | $78 |
| Omeprazole | 72 | $1,006 | $14 |
| Pantoprazole | 54 | $778 | $14 |
| Lansoprazole | 17 | $692 | $41 |
| Gavilyte-N | 40 | $631 | $16 |
| Sulfasalazine | 11 | $259 | $24 |
| Trilyte With Flavor Packets | 13 | $217 | $17 |
| Metoclopramide | 16 | $121 | $8 |
| Dicyclomine | 12 | $100 | $8 |
2013: 14 drugs
| Viread | 30 | $25,830 | $861 |
| Nexium | 61 | $22,549 | $370 |
| Aciphex | 36 | $18,983 | $527 |
| Dexilant | 60 | $11,716 | $195 |
| Pantoprazole | 100 | $2,257 | $23 |
| Suprep | 28 | $2,022 | $72 |
| Omeprazole | 81 | $1,269 | $16 |
| Moviprep | 17 | $1,212 | $71 |
| Lansoprazole | 11 | $1,211 | $110 |
| Polyethylene Glycol 3350 | 17 | $632 | $37 |
| Peg-3350 With Flavor Packs | 23 | $424 | $18 |
| Peg 3350-Electrolyte | 19 | $218 | $11 |
| Dicyclomine | 19 | $117 | $6 |
| Metoclopramide | 14 | $98 | $7 |
Money from drug and device companies
$55 in 2021
A payment is not proof that care is biased.
| Janssen Biotech | Stelara | $36 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $19 | 1 payment
|
See all 2 published payments
| GlaxoSmithKline | Meals · 2021-09-15 | Trelegy Ellipta | $19 |
| Janssen Biotech | Meals · 2021-08-06 | Stelara | $36 |
Professional record
- NPI
- 1669662896
- Licence
- CA A87725California A87725: Current · expires 2027-11-30
- Trained
- University of Michigan Medical School, 2002
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA GR0092050
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2007-07-25
- NPI last updated
- 2018-11-19
This is when the NPI record was last certified, not a medical board exam.